Original Research

Pegylated-interferon plus ribavirin treatment does not alter the prevalence of resistance-associated substitutions to direct-acting antivirals in HCV genotype 1a patients

Chen Z, Pang X, Li Z, Ren H, Hu P

Infection and Drug Resistance 2017, 10:275-281

Published Date: 31 August 2017